TG Therapeutics TGTX Long-term investments
Long-term investments at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ShortTermInvestments.
The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about TG Therapeutics's long-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TG Therapeutics's long-term investments?
- TG Therapeutics (TGTX) reported long-term investments of $72.22M in Q1 2026.
- How has TG Therapeutics's long-term investments changed year-over-year?
- TG Therapeutics's long-term investments decreased by 49.9% year-over-year, from $144.1M to $72.22M.
- What is the long-term trend for TG Therapeutics's long-term investments?
- Over 3 years (2022 to 2025), TG Therapeutics's long-term investments has grown at a 1.9% compound annual growth rate (CAGR), from $59.37M to $62.82M.
- What does long-term investments mean?
- Investments that the company does not expect to convert into cash within the next twelve months.
- How do you interpret long-term investments?
- An increase indicates the deployment of excess capital into longer-term vehicles, while a decrease may signal a need for liquidity.
- How does long-term investments compare across companies?
- Varies widely based on corporate treasury policy and the stage of the company's product pipeline.